↓ Skip to main content

Dove Medical Press

Apatinib mesylate tablet in the treatment of advanced malignant melanoma

Overview of attention for article published in OncoTargets and therapy, August 2018
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Readers on

mendeley
6 Mendeley
Title
Apatinib mesylate tablet in the treatment of advanced malignant melanoma
Published in
OncoTargets and therapy, August 2018
DOI 10.2147/ott.s175507
Pubmed ID
Authors

Lingge Yang, Huiyan Zhu, Peng Luo, Shiqi Chen, Yu Xu, Chunmeng Wang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 17%
Student > Postgraduate 1 17%
Student > Doctoral Student 1 17%
Unknown 3 50%
Readers by discipline Count As %
Medicine and Dentistry 2 33%
Computer Science 1 17%
Unknown 3 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2018.
All research outputs
#22,867,974
of 25,498,750 outputs
Outputs from OncoTargets and therapy
#2,088
of 3,021 outputs
Outputs of similar age
#299,311
of 342,157 outputs
Outputs of similar age from OncoTargets and therapy
#75
of 114 outputs
Altmetric has tracked 25,498,750 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,021 research outputs from this source. They receive a mean Attention Score of 2.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,157 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.